Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
HLX07 (pimurutamab) is a humanized monoclonal antibody directed against EGFR, which was demonstrated to have increased affinity for Egfr compared to cetuximab and may result in antitumor activity (PMID: 33713216).
|DrugClasses||EGFR Antibody 43|
|CAS Registry Number||2251771-76-1|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|